2024-02-25 06:20:33 ET
Summary
- Hims & Hers Health stock has rallied over 50% since our previous "Strong Buy" article, but the stock may be overextended, and earnings are approaching.
- The company's subscription model, market opportunity, and undervalued multiple were the main reasons for our original bullish thesis, and remain relevant today.
- Recent updates show strong revenue growth, improving economics, and continued execution of a successful land & expand strategy, but the stock's performance may be reflecting these positives.
- Selling put options might be the best way to balance risk and reward going into earnings, over the short and medium term.
A few months ago, we wrote an article about Hims & Hers Health ( HIMS ) titled: " Hims & Hers: 3 Reasons To Buy This Potential Growth Stock ".
In that article, we made the case that the stock was incredibly undervalued when compared to the company's growth opportunity and TAM over the long term....
Read the full article on Seeking Alpha
For further details see:
Hims & Hers: Turning The Profitability Corner And Returning 28%